InvestSMART

Truscreen Group Limited (ASX:TRU)

ALERT: Price-sensitive ASX Announcement for TRU
Current share price for TRU : $0.008 -0.009 (-52.94%)+
Announcement
Release
29 May 2026 7:30AM
Price at Release
$0.017
Full Release
download
Summary
Truscreen Group Limited reported a 42% increase in product sales for FY2026, driven by an expanded global distribution network and new market entries in India and Indonesia. The company submitted proposals for cervical cancer screening programs to UNITAID, targeting 14 high burden countries. Despite a net loss of $2.25 million, Truscreen maintained a gross margin of 31.5% and raised approximately $4 million in capital, focusing on strategic geographic expansion and public screening programs to improve financial performance.
Key Points
  • Truscreen Group Limited achieved a 42% year-over-year (YOY) growth in product sales for FY2026.
  • The company expanded its distribution network globally, including new markets in India and Indonesia.
  • Truscreen submitted proposals for cervical cancer screening programs to UNITAID, covering 14 high burden countries.
  • The company's gross margin for FY2026 was 31.5%, with expectations of further improvement in FY2027.
  • Truscreen reported a loss of $2.25 million for FY2026, similar to the previous year.
  • Total overhead expenses increased to $3.4 million due to marketing and support costs.
  • The company raised approximately $4 million through share issues.
  • Truscreen's strategic focus includes participating in public screening programs and expanding its geographic reach.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.